Thomas M. Krummel - 17 Sep 2021 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
Director
Signature
/s/ Alaleh Nouri, Attorney-in-Fact for Thomas M. Krummell
Issuer symbol
PRCT
Transactions as of
17 Sep 2021
Net transactions value
+$125,000
Form type
4
Filing time
21 Sep 2021, 18:35:05 UTC
Previous filing
16 Sep 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Conversion of derivative security +5,963 +8.5% 75,919 17 Sep 2021 Direct F1
transaction PRCT Common Stock Purchase $125,000 +5,000 +6.6% $25.00 80,919 17 Sep 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Series C Convertible Preferred Stock Conversion of derivative security -5,963 -100% 0 17 Sep 2021 Common Stock 5,963 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock , Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock (collectively, the "Preferred Stock") will convert automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date.
F2 Represents a purchase in the Issuer's public offering.